ALLURION TECHNOLOGIES, INC.
For the period ended Dec 31, 2025. Filed Mar 30, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Allurion Technologies, Inc. | |
| By: | /s/ Shantanu Gaur |
| Shantanu Gaur | |
| Chief Executive Officer |
POWER OF ATTORNEY
Each person whose individual signature appears below hereby constitutes and appoints Shantanu Gaur and Brendan Gibbons, and each of them, with full power of substitution and re-substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Name | Title | Date |
|---|---|---|
| /s/ Shantanu Gaur | Chief Executive Officer and Director(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) | March 30, 2026 |
| Shantanu Gaur | ||
| /s/ Michael Davin | Director | March 30, 2026 |
| Michael Davin | ||
| Director | March 30, 2026 | |
| Krishna Gupta | ||
| /s/ Larson Douglas Hudson | Director | March 30, 2026 |
| Larson Douglas Hudson | ||
| /s/ Omar Ishrak | Director | March 30, 2026 |
| Omar Ishrak | ||
| /s/ Keith B. Johns II | Director | March 30, 2026 |
| Keith B. Johns II | ||
| /s/ Nicholas Lewin | Director | March 30, 2026 |
| Nicholas Lewin | ||
| /s/ R. Jason Richey | Director | March 30, 2026 |
| R. Jason Richey | ||
INDEX TO FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 34) | F-2 |
|---|---|
| Consolidated Balance Sheets as of December 31, 2025 and 2024 | F-3 |
| Consolidated Statements of Operations for the Years Ended December 31, 2025 and 2024 | F-4 |
| Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2025 and 2024 | F-5 |
| Consolidated Statements of Stockholders’ Deficit for the Years Ended December 31, 2025 and 2024 | F-6 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2025 and 2024 | F-7 |
| Notes to Consolidated Financial Statements | F-8 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.